Glix 13, a new drug acting on glutamatergic pathways in children and animal models of autism spectrum disorders
about
Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials.Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13).Pharmacogenomic medicine in autism: challenges and opportunities.Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature.Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice.
P2860
Glix 13, a new drug acting on glutamatergic pathways in children and animal models of autism spectrum disorders
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Glix 13, a new drug acting on ...... s of autism spectrum disorders
@en
type
label
Glix 13, a new drug acting on ...... s of autism spectrum disorders
@en
prefLabel
Glix 13, a new drug acting on ...... s of autism spectrum disorders
@en
P2093
P2860
P50
P921
P356
P1476
Glix 13, a new drug acting on ...... s of autism spectrum disorders
@en
P2093
Carla Sogos
Giovanna Maria Pierantoni
Raffaele Gerlini
Rosamaria Iorio
Yinka Olabinjo
P2860
P304
P356
10.1155/2014/234295
P407
P5008
P577
2014-01-30T00:00:00Z